good news

AugusMax
2021-11-03

good news

Ocugen has added ~6.5% in the pre-market after its partner Bharat Biotech was granted the Emergency Use Listing (EUL) for its COVID-19 vaccine by the World Health Organization (WHO) on Wednesday.


Ocugen has partnered with Bharat Biotech to co-develop the vaccine for the U.S. market. Last week, the company said it requested FDA clearance to start a U.S.-based late-stage study for COVAXIN.

$Histogenics(OCGN)$

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法